AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « immunosuppressive »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
immunosuppression < immunosuppressive < immunotherapeutic  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 31.
[0-20] [0 - 20][0 - 31][20-30][20-40]
Ident.Authors (with country if any)Title
000006 (2020) Anna Jakubczyc ; Claus Neurohr[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000038 (2020) Maria C. Cid [Espagne] ; Roberto Ríos-Garcés [Espagne] ; Nekane Terrades-García [Espagne] ; Georgina Espígol-Frigolé [Espagne]Treatment of giant-cell arteritis: from broad spectrum immunosuppressive agents to targeted therapies.
000051 (2020) Eun Hye Park [Corée du Sud] ; Eun Young Lee [Corée du Sud] ; Kichul Shin [Corée du Sud] ; Hyoun-Ah Kim [Corée du Sud]Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
000079 (2020) Caterina Vacchi [Italie] ; Marco Sebastiani [Italie] ; Giulia Cassone [Italie] ; Stefania Cerri [Italie] ; Giovanni Della Casa [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
000081 (2020) Francisco Vílchez-Oya [Espagne] ; Julia María Sánchez-Schmidt [Espagne] ; Anna Agustí [Espagne] ; Ana Pros [Espagne]The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review.
000099 (2020) Carlo Perricone [Italie] ; Paola Triggianese [Italie] ; Elena Bartoloni [Italie] ; Giacomo Cafaro [Italie] ; Angelo F. Bonifacio [Italie] ; Roberto Bursi [Italie] ; Roberto Perricone [Italie] ; Roberto Gerli [Italie]The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
000113 (2020) José M. Carballido [Suisse] ; Camille Regairaz [Suisse] ; Celine Rauld [Suisse] ; Layla Raad [Suisse] ; Damien Picard [Suisse] ; Michael Kammüller [Suisse]The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases
000115 (2020) Philip C. Robinson [Australie] ; Jinoos Yazdany [États-Unis]The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
000140 (2020) Yusho Ishii [Japon] ; Hiroshi Fujii [Japon] ; Koichiro Sugimura [Japon] ; Tsuyoshi Shirai [Japon] ; Yosuke Hoshi [Japon] ; Yoko Fujita [Japon] ; Yuko Shirota [Japon] ; Tomonori Ishii [Japon] ; Hiroaki Shimokawa [Japon] ; Hideo Harigae [Japon]Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody
000187 (2020) Durga Prasanna Misra [Inde] ; Vikas Agarwal [Inde] ; Armen Yuri Gasparyan ; Olena Zimba [Ukraine]Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
000197 (2020) Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie]Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
000206 (2020) Christos Koutsianas ; Konstantinos Thomas ; Dimitrios VassilopoulosReactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
000214 (2020) Alyson W. Wong [Canada] ; Christopher J. Ryerson [Canada] ; Sabina A. Guler [Suisse]Progression of fibrosing interstitial lung disease
000286 (2020) Tiago Torres [Portugal] ; Luis Puig [Espagne]Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
000290 (2020) Federico Alberici [Italie] ; Elisa Delbarba [Italie] ; Chiara Manenti [Italie] ; Laura Econimo [Italie] ; Francesca Valerio [Italie] ; Alessandra Pola [Italie] ; Camilla Maffei [Italie] ; Stefano Possenti [Italie] ; Simone Piva [Italie] ; Nicola Latronico [Italie] ; Emanuele Focà [Italie] ; Francesco Castelli [Italie] ; Paola Gaggia [Italie] ; Ezio Movilli [Italie] ; Sergio Bove [Italie] ; Fabio Malberti [Italie] ; Marco Farina [Italie] ; Martina Bracchi [Italie] ; Ester Maria Costantino [Italie] ; Nicola Bossini [Italie] ; Mario Gaggiotti [Italie] ; Francesco Scolari [Italie]Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy
000293 (2020) Hermine I. Brunner [États-Unis] ; Nikolay Tzaribachev [Allemagne] ; Gabriel Vega Cornejo ; Rik Joos [Belgique] ; Elisabeth Gervais [France] ; Rolando Cimaz [Italie] ; Inmaculada Calvo Penadés [Espagne] ; Rubén Cuttica [Argentine] ; Thomas Lutz [Allemagne] ; Pierre Quartier [France] ; Yash Gandhi [États-Unis] ; Marleen Nys [Belgique] ; Robert Wong [États-Unis] ; Alberto Martini [Italie] ; Daniel J. Lovell [États-Unis] ; Nicolino Ruperto [Italie]Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2–5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept
000299 (2020) Daniel H. Glaser [États-Unis] ; Christina Schutt [États-Unis] ; Kaila Schollaert-Fitch [États-Unis] ; Kathryn Torok [États-Unis]Linear Scleroderma of the Head - Updates in management of Parry Romberg Syndrome and En coup de sabre: A rapid scoping review across subspecialties
000307 (2020) Ethan S. Sen [Royaume-Uni] ; A V Ramanan [Royaume-Uni]Juvenile idiopathic arthritis-associated uveitis.
000350 (2020) Anna-Sophia Kattner ; Ernst Holler ; Barbara Holler ; Sebastian Klobuch ; Daniela Weber ; Danilo Martinovic ; Matthias Edinger ; Wolfgang Herr ; Daniel WolffIL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
000354 (2020) Chiara Minotti [Italie] ; Francesca Tirelli [Italie] ; Elisa Barbieri [Italie] ; Carlo Giaquinto [Italie] ; Daniele Donà [Italie]How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review
000377 (2020) Yan Zhang [République populaire de Chine] ; Ming Hu [République populaire de Chine] ; Dong Wei [République populaire de Chine] ; Hui Zhang [République populaire de Chine] ; Bao Chu [République populaire de Chine] ; Hao-Ming Xu [République populaire de Chine] ; Tao Wang [République populaire de Chine]From Severe Herpes Zoster to Rare Suid Herpesvirus Encephalitis: A New Twist of the Varicellovirus Genus Infection in Patients with Kidney Diseases

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "immunosuppressive" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "immunosuppressive" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    immunosuppressive
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021